![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PRELID2 |
Gene summary for PRELID2 |
![]() |
Gene information | Species | Human | Gene symbol | PRELID2 | Gene ID | 153768 |
Gene name | PRELI domain containing 2 | |
Gene Alias | PRELID2 | |
Cytomap | 5q32 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q8N945 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
153768 | PRELID2 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.91e-20 | -6.33e-01 | 0.0155 |
153768 | PRELID2 | HTA11_2951_2000001011 | Human | Colorectum | AD | 9.92e-08 | -8.46e-01 | 0.0216 |
153768 | PRELID2 | HTA11_1938_2000001011 | Human | Colorectum | AD | 2.16e-03 | 4.93e-01 | -0.0811 |
153768 | PRELID2 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.01e-10 | 6.54e-01 | -0.1954 |
153768 | PRELID2 | HTA11_3361_2000001011 | Human | Colorectum | AD | 4.78e-02 | -4.96e-01 | -0.1207 |
153768 | PRELID2 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.72e-24 | -7.14e-01 | 0.096 |
153768 | PRELID2 | HTA11_8622_2000001021 | Human | Colorectum | SER | 2.72e-08 | -6.40e-01 | 0.0528 |
153768 | PRELID2 | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.50e-03 | -3.35e-01 | 0.0674 |
153768 | PRELID2 | HTA11_11156_2000001011 | Human | Colorectum | AD | 1.37e-03 | -8.48e-01 | 0.0397 |
153768 | PRELID2 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 2.05e-32 | -8.03e-01 | 0.294 |
153768 | PRELID2 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.52e-04 | -3.54e-01 | 0.3859 |
153768 | PRELID2 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 4.54e-52 | -1.05e+00 | 0.3005 |
153768 | PRELID2 | F007 | Human | Colorectum | FAP | 1.46e-04 | 2.22e-01 | 0.1176 |
153768 | PRELID2 | A001-C-207 | Human | Colorectum | FAP | 8.97e-08 | -5.25e-01 | 0.1278 |
153768 | PRELID2 | A015-C-203 | Human | Colorectum | FAP | 1.00e-23 | -4.05e-01 | -0.1294 |
153768 | PRELID2 | A015-C-204 | Human | Colorectum | FAP | 2.40e-02 | -1.13e-01 | -0.0228 |
153768 | PRELID2 | A014-C-040 | Human | Colorectum | FAP | 3.25e-04 | -4.60e-01 | -0.1184 |
153768 | PRELID2 | A002-C-201 | Human | Colorectum | FAP | 3.52e-12 | -3.20e-01 | 0.0324 |
153768 | PRELID2 | A001-C-119 | Human | Colorectum | FAP | 5.96e-18 | -8.53e-01 | -0.1557 |
153768 | PRELID2 | A001-C-108 | Human | Colorectum | FAP | 3.15e-19 | -5.54e-01 | -0.0272 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0010876 | Colorectum | AD | lipid localization | 120/3918 | 448/18723 | 1.59e-03 | 1.33e-02 | 120 |
GO:0006869 | Colorectum | AD | lipid transport | 108/3918 | 398/18723 | 1.67e-03 | 1.39e-02 | 108 |
GO:0015748 | Colorectum | AD | organophosphate ester transport | 42/3918 | 140/18723 | 7.04e-03 | 4.31e-02 | 42 |
GO:00108761 | Colorectum | MSS | lipid localization | 104/3467 | 448/18723 | 6.76e-03 | 4.38e-02 | 104 |
GO:00068691 | Colorectum | FAP | lipid transport | 81/2622 | 398/18723 | 2.84e-04 | 3.76e-03 | 81 |
GO:00108762 | Colorectum | FAP | lipid localization | 85/2622 | 448/18723 | 1.92e-03 | 1.63e-02 | 85 |
GO:0015914 | Colorectum | FAP | phospholipid transport | 23/2622 | 96/18723 | 6.09e-03 | 3.82e-02 | 23 |
GO:00068692 | Colorectum | CRC | lipid transport | 63/2078 | 398/18723 | 2.36e-03 | 2.26e-02 | 63 |
GO:00108763 | Colorectum | CRC | lipid localization | 68/2078 | 448/18723 | 4.60e-03 | 3.58e-02 | 68 |
GO:001087621 | Liver | HCC | lipid localization | 228/7958 | 448/18723 | 1.80e-04 | 1.41e-03 | 228 |
GO:01200092 | Liver | HCC | intermembrane lipid transfer | 33/7958 | 48/18723 | 2.12e-04 | 1.63e-03 | 33 |
GO:000686921 | Liver | HCC | lipid transport | 198/7958 | 398/18723 | 1.92e-03 | 9.78e-03 | 198 |
GO:00159142 | Lung | IAC | phospholipid transport | 20/2061 | 96/18723 | 3.58e-03 | 3.00e-02 | 20 |
GO:00157482 | Lung | IAC | organophosphate ester transport | 26/2061 | 140/18723 | 5.22e-03 | 3.97e-02 | 26 |
GO:001591411 | Lung | AIS | phospholipid transport | 18/1849 | 96/18723 | 5.64e-03 | 4.76e-02 | 18 |
GO:00157483 | Oral cavity | EOLP | organophosphate ester transport | 28/2218 | 140/18723 | 3.66e-03 | 2.05e-02 | 28 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PRELID2 | SNV | Missense_Mutation | novel | c.209C>T | p.Ser70Phe | p.S70F | Q8N945 | protein_coding | tolerated_low_confidence(0.71) | benign(0.001) | TCGA-DS-A7WH-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
PRELID2 | SNV | Missense_Mutation | c.220C>G | p.Leu74Val | p.L74V | Q8N945 | protein_coding | tolerated_low_confidence(0.58) | benign(0.113) | TCGA-IR-A3LA-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
PRELID2 | SNV | Missense_Mutation | c.244N>A | p.Val82Met | p.V82M | Q8N945 | protein_coding | tolerated(0.11) | possibly_damaging(0.682) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
PRELID2 | SNV | Missense_Mutation | novel | c.551N>T | p.Gly184Val | p.G184V | Q8N945 | protein_coding | deleterious(0.01) | probably_damaging(0.965) | TCGA-AX-A06F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
PRELID2 | SNV | Missense_Mutation | rs761566160 | c.115N>G | p.Ile39Val | p.I39V | Q8N945 | protein_coding | tolerated(0.47) | benign(0.003) | TCGA-B5-A1MZ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
PRELID2 | SNV | Missense_Mutation | novel | c.348G>T | p.Gln116His | p.Q116H | Q8N945 | protein_coding | tolerated(0.08) | probably_damaging(0.927) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
PRELID2 | SNV | Missense_Mutation | novel | c.16G>A | p.Asp6Asn | p.D6N | Q8N945 | protein_coding | deleterious(0.01) | benign(0.343) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
PRELID2 | SNV | Missense_Mutation | novel | c.382N>A | p.Glu128Lys | p.E128K | Q8N945 | protein_coding | tolerated(0.21) | possibly_damaging(0.872) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PRELID2 | SNV | Missense_Mutation | novel | c.302G>T | p.Arg101Leu | p.R101L | Q8N945 | protein_coding | deleterious(0.02) | benign(0.134) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PRELID2 | SNV | Missense_Mutation | novel | c.95N>C | p.Lys32Thr | p.K32T | Q8N945 | protein_coding | deleterious(0.02) | possibly_damaging(0.832) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |